CBD Stocks

Why Aurora’s Latest CBD Play is a Big Deal

Why Aurora’s Latest CBD Play is a Big Deal

Aurora completes the acquisition of Hempco So what? Now what? Of course, whether Aurora benefits from this opportunity depends in part on the company’s ability to properly execute its plans. However, this move is a reminder that Aurora is playing the long game....

5 Cannabis Stocks Set for Massive Gains

Shutterstock photo InvestorPlace – Stock Market News, Stock Advice & Trading Tips Cannabis stocks can deliver potentially very lucrative returns. After all we are on the brink of a massive market opportunity. For instance, a new report by Grand View Research...

CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge

You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.

Hemp and CBD Arise as Alternatives to the Tobacco Industry

The MarketWatch News Department was not involved in the creation of this content. NEW YORK, Aug. 3, 2020 /PRNewswire via COMTEX/ —NEW YORK, Aug. 3, 2020 /PRNewswire/ — The tobacco industry is a major market, and in some aspects, it is evolving to adapt to...

GW Pharma Scores New FDA Approval For CBD Drug Epidiolex

GW Pharma Scores New FDA Approval For CBD Drug Epidiolex

Shares in GWPH have surged 22% year-to-date, and analysts have a bullish Strong Buy consensus on the stock’s outlook. That’s with an average analyst price target of $175 for upside potential of 37%. (See GWPH stock analysis on TipRanks). Related News:UK...

Down 25% in a Month, CGC Stock Could Fall Further

Down 25% in a Month, CGC Stock Could Fall Further

CGC released earnings on Aug. 14. For the quarter ending June 30, net revenue was C$90.5 million, down from C$94.1 million in the prior quarter. Overestimating demand for CBD oils and capsules, Canopy lost out while its peers such as Aurora Cannabis (NYSE:ACB)...

Aurora Cannabis Doubles Down on U.S. CBD Market

Aurora Cannabis (NYSE:ACB) is continuing to spread its bets across product lines and markets far and wide. With a market cap now standing at $5.9 billion, the Edmonton, Canada-based marijuana stock is the second-largest cannabis company in the sector just behind...